The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SGNTV-001: Open label phase 2 study of tisotumab vedotin for locally advanced or metastatic disease in solid tumors.
 
David S. Hong
Stock and Other Ownership Interests - MolecularMatch; Oncorena; Presagia
Honoraria - Adaptimmune; Baxter; Bayer; Merrimack
Consulting or Advisory Role - Adaptimmune; Alphasights; Axiom Biotechnologies; Baxter; Bayer; Eisai; Genentech; Gerson Lehrman Group; GroupH; Guidepoint Global; Janssen; Medscape; Merrimack; Numab; Pfizer; Seagen; Takeda; Trieza Therapeutics
Research Funding - Abbvie; Adaptimmune; Amgen; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Fate Therapeutics; Genentech; Genmab; Ignyta; Infinity Pharmaceuticals; Kite, a Gilead company; Kyowa Hakko Kirin; Lilly; Loxo; MedImmune; Merck; Mirati Therapeutics; miRNA Therapeutics; Molecular Templates; MOLOGEN; National Cancer Institute; Novartis; Pfizer; Seagen; Takeda
Travel, Accommodations, Expenses - Genmab; Loxo; miRNA Therapeutics
 
Omid S. Tehrani
Honoraria - Pfizer
Research Funding - Seagen
Travel, Accommodations, Expenses - Pfizer
 
Howard Safran
No Relationships to Disclose
 
Conor Ernst Steuer
Honoraria - Merck
Consulting or Advisory Role - Abbvie; ARMO BioSciences; BerGenBio
Research Funding - Vaccinex
 
Jill Lacy
Consulting or Advisory Role - AstraZeneca; Celgene; KeyQuest Health; Navigant Consulting; Sirtex Medical
Travel, Accommodations, Expenses - Lilly
 
Matthew H. Taylor
Consulting or Advisory Role - ArQule; Array BioPharma; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Eisai; Loxo; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Eisai
 
Thomas J. George
Consulting or Advisory Role - Bayer/Onyx; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); Bayer/Onyx (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Newlink Genetics (Inst); Pharmacyclics (Inst); Seagen (Inst); Tesaro (Inst)
 
Reshma A. Rangwala
Employment - Genmab; Genmab; Genmab
Stock and Other Ownership Interests - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Genmab; Merck Sharp & Dohme
 
Shweta Jain
No Relationships to Disclose
 
Leonardo Viana Nicacio
Employment - Seagen
Stock and Other Ownership Interests - Florence Healthcare
Honoraria - Seagen
Travel, Accommodations, Expenses - Seagen
 
May Thet Cho
Consulting or Advisory Role - Amgen
Research Funding - Bristol-Myers Squibb (Inst); Seagen (Inst)